Cite
HARVARD Citation
Smith, G. et al. (n.d.). 018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity. Heart. pp. A12-A13. [Online].